This company has been marked as potentially delisted and may not be actively trading. bluebird bio (BLUE) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock bluebird bio (NASDAQ:BLUE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$3.23K Get BLUE Insider Trade Alerts Want to know when executives and insiders are buying or selling bluebird bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BLUE Insider Buying and Selling by Quarter bluebird bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/3/2025Andrew ObenshainCEOSell86$7.39$635.54 2/3/2025Thomas J KlimaInsiderSell122$7.39$901.58 1/6/2025Andrew ObenshainCEOSell140$9.24$1,293.60 12/10/2024Andrew ObenshainCEOSell48$8.40$403.20 (Data available from 1/1/2013 forward) BLUE Insider Trading Activity - Frequently Asked Questions Who is on bluebird bio's Insider Roster? The list of insiders at bluebird bio includes Andrew Obenshain, Christopher Krawtschuk, Jason Cole, Nick Leschly, Richard A Colvin, and Thomas J Klima. Learn more on insiders at BLUE. What percentage of bluebird bio stock is owned by insiders? 1.40% of bluebird bio stock is owned by insiders. Learn more on BLUE's insider holdings. Which bluebird bio insiders have been selling company stock? The following insiders have sold BLUE shares in the last 24 months: Andrew Obenshain ($68,421.94), Christopher Krawtschuk ($20,430.40), Richard A Colvin ($823.60), and Thomas J Klima ($6,818.38). How much insider selling is happening at bluebird bio? Insiders have sold a total of 1,929 bluebird bio shares in the last 24 months for a total of $96,494.32 sold. bluebird bio Key ExecutivesMr. Andrew Obenshain (Age 50)President, CEO & Director Compensation: $1.04M1 recent tradesMr. Thomas J. Klima (Age 52)Chief Commercial Officer & COO Compensation: $654.97k1 recent tradesMr. Richard A. Colvin M.D. (Age 58)Ph.D., Chief Medical Officer Compensation: $696.24kMr. Oliver James Sterling IIICFO & Principal Accounting OfficerMr. Joseph D. Vittiglio Esq. (Age 52)J.D., Chief Legal & Business Officer and Secretary Jess RowlandsHead of Corporate CommunicationsMs. Andrea WaltonChief People OfficerMr. Kasra KasraianSenior Vice President of Technical Development & OperationsMr. Scott ShoemakerSenior Vice President of QualityMs. Sarah AlspachSenior Vice President of External Affairs More Insider Trading Tools from MarketBeat Related Companies CytomX Therapeutics Insider Trading Voyager Therapeutics Insider Trading Kyverna Therapeutics Insider Trading Bright Minds Biosciences Insider Trading Galectin Therapeutics Insider Trading Journey Medical Insider Trading DiaMedica Therapeutics Insider Trading Nuvectis Pharma Insider Trading Puma Biotechnology Insider Trading Aclaris Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:BLUE) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bluebird bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bluebird bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLUE Stock Alerts